Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach

We investigated the clinical relevance of SLC 19A1 genetic variability for high dose methotrexate (HD-MTX) related toxicities in children and adolescents with acute lymphoblastic leukaemia (ALL) and non Hodgkin malignant lymphoma (NHML).

Bibliographic Details
Main Authors: Kotnik Barbara Faganel, Jazbec Janez, Grabar Petra Bohanec, Rodriguez-Antona Cristina, Dolzan Vita
Format: Article
Language:English
Published: Sciendo 2017-09-01
Series:Radiology and Oncology
Subjects:
Online Access:https://doi.org/10.1515/raon-2017-0040
_version_ 1819115348631224320
author Kotnik Barbara Faganel
Jazbec Janez
Grabar Petra Bohanec
Rodriguez-Antona Cristina
Dolzan Vita
author_facet Kotnik Barbara Faganel
Jazbec Janez
Grabar Petra Bohanec
Rodriguez-Antona Cristina
Dolzan Vita
author_sort Kotnik Barbara Faganel
collection DOAJ
description We investigated the clinical relevance of SLC 19A1 genetic variability for high dose methotrexate (HD-MTX) related toxicities in children and adolescents with acute lymphoblastic leukaemia (ALL) and non Hodgkin malignant lymphoma (NHML).
first_indexed 2024-12-22T04:59:46Z
format Article
id doaj.art-45d8f75f9cc44598a34dd45aa5202e7b
institution Directory Open Access Journal
issn 1581-3207
language English
last_indexed 2024-12-22T04:59:46Z
publishDate 2017-09-01
publisher Sciendo
record_format Article
series Radiology and Oncology
spelling doaj.art-45d8f75f9cc44598a34dd45aa5202e7b2022-12-21T18:38:18ZengSciendoRadiology and Oncology1581-32072017-09-0151445546210.1515/raon-2017-0040raon-2017-0040Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approachKotnik Barbara Faganel0Jazbec Janez1Grabar Petra Bohanec2Rodriguez-Antona Cristina3Dolzan Vita4Department of Oncology and Haematology, University Children’s Hospital, University Medical Centre Ljubljana, Ljubljana, SloveniaDepartment of Oncology and Haematology, University Children’s Hospital, University Medical Centre Ljubljana, Ljubljana, SloveniaPharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, SloveniaHereditary Endocrine Cancer Group Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid, SpainPharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, SloveniaWe investigated the clinical relevance of SLC 19A1 genetic variability for high dose methotrexate (HD-MTX) related toxicities in children and adolescents with acute lymphoblastic leukaemia (ALL) and non Hodgkin malignant lymphoma (NHML).https://doi.org/10.1515/raon-2017-0040acute lymphoblastic leukaemiagenetic polymorphismhaplotypemethotrexate
spellingShingle Kotnik Barbara Faganel
Jazbec Janez
Grabar Petra Bohanec
Rodriguez-Antona Cristina
Dolzan Vita
Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach
Radiology and Oncology
acute lymphoblastic leukaemia
genetic polymorphism
haplotype
methotrexate
title Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach
title_full Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach
title_fullStr Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach
title_full_unstemmed Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach
title_short Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach
title_sort association between slc19a1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non hodgkin malignant lymphoma introducing a haplotype based approach
topic acute lymphoblastic leukaemia
genetic polymorphism
haplotype
methotrexate
url https://doi.org/10.1515/raon-2017-0040
work_keys_str_mv AT kotnikbarbarafaganel associationbetweenslc19a1genepolymorphismandhighdosemethotrexatetoxicityinchildhoodacutelymphoblasticleukaemiaandnonhodgkinmalignantlymphomaintroducingahaplotypebasedapproach
AT jazbecjanez associationbetweenslc19a1genepolymorphismandhighdosemethotrexatetoxicityinchildhoodacutelymphoblasticleukaemiaandnonhodgkinmalignantlymphomaintroducingahaplotypebasedapproach
AT grabarpetrabohanec associationbetweenslc19a1genepolymorphismandhighdosemethotrexatetoxicityinchildhoodacutelymphoblasticleukaemiaandnonhodgkinmalignantlymphomaintroducingahaplotypebasedapproach
AT rodriguezantonacristina associationbetweenslc19a1genepolymorphismandhighdosemethotrexatetoxicityinchildhoodacutelymphoblasticleukaemiaandnonhodgkinmalignantlymphomaintroducingahaplotypebasedapproach
AT dolzanvita associationbetweenslc19a1genepolymorphismandhighdosemethotrexatetoxicityinchildhoodacutelymphoblasticleukaemiaandnonhodgkinmalignantlymphomaintroducingahaplotypebasedapproach